West Pharmaceutical Services Inc (WST) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, West Pharmaceutical Services reported revenue of $3.07B, up 6.3% from $2.89B the year before. Net income was $493.7M (a 16.1% net margin), or $6.79 per diluted share. Gross margin was 35.9% and operating margin was 19.0%. Operating activities generated $754.8M of cash, leaving $468.9M of free cash flow. At fiscal year end, West Pharmaceutical Services held $4.27B in total assets against $1.09B in total liabilities, including $791.3M of cash and equivalents.
Open the full interactive West Pharmaceutical Services financials → Quarterly statements, key ratios, valuation history and price charts.
West Pharmaceutical Services Key Stats
| Share Price | $371.82 |
|---|---|
| Market Cap | $26.51B |
| P/E Ratio | 54.8 |
| Revenue YoY Growth | +6.2% |
| 52-Week Range | $230.63 – $376.76 |
| Shares Outstanding | 70.8 million (basic, 2026 Q2) |
West Pharmaceutical Services Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.15B | $2.83B | $2.89B | $2.95B | $2.89B | $3.07B |
| Cost of Goods Sold | $1.38B | $1.66B | $1.75B | $1.82B | $1.89B | $1.97B |
| Gross Profit | $767.8M | $1.18B | $1.14B | $1.13B | $998.5M | $1.10B |
| Operating Income | $406.9M | $752.3M | $734.0M | $676.0M | $569.9M | $584.9M |
| Pre-Tax Income | $401.3M | $748.9M | $679.9M | $698.0M | $585.5M | $600.9M |
| Income Tax | $72.5M | $107.2M | $114.7M | $122.3M | $107.5M | $121.6M |
| Net Income | $346.2M | $661.8M | $585.9M | $593.4M | $492.7M | $493.7M |
| Diluted EPS | $4.57 | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
West Pharmaceutical Services Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $804.6M | $805.0M | $844.9M | $872.3M |
| Net Income | $140.0M | $132.1M | $138.8M | $154.0M |
| Diluted EPS | $1.92 | $1.82 | $1.92 | $2.15 |
West Pharmaceutical Services Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $615.5M | $762.6M | $894.3M | $853.9M | $484.6M | $791.3M |
| Current Assets | $1.37B | $1.74B | $1.92B | $1.94B | $1.54B | $1.98B |
| Total Assets | $2.79B | $3.31B | $3.62B | $3.83B | $3.64B | $4.27B |
| Current Liabilities | $503.4M | $594.1M | $519.0M | $671.8M | $550.4M | $654.9M |
| Total Long-Term Debt | $255.2M | $253.0M | $208.9M | $206.8M | $202.6M | $202.8M |
| Total Liabilities | $939.3M | $978.4M | $931.9M | $948.5M | $961.1M | $1.09B |
| Shareholders' Equity | $1.85B | $2.34B | $2.68B | $2.88B | $2.68B | $3.18B |
West Pharmaceutical Services Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $472.5M | $584.0M | $724.0M | $776.5M | $653.4M | $754.8M |
| Cash From Investing | -$179.5M | -$253.1M | -$288.2M | -$368.7M | -$378.7M | -$285.9M |
| Cash From Financing | -$137.1M | -$168.1M | -$293.6M | -$459.6M | -$622.6M | -$185.1M |
| Free Cash Flow | $298.1M | $330.6M | $439.4M | $414.5M | $276.4M | $468.9M |
Figures from West Pharmaceutical Services' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full West Pharmaceutical Services financials page for every line item.
West Pharmaceutical Services Company Profile
| Ticker | WST |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Exton, Pennsylvania |
| Incorporated in | Pennsylvania |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000105770 |
Frequently Asked Questions
What was West Pharmaceutical Services' revenue in fiscal 2025?
West Pharmaceutical Services (WST) reported revenue of $3.07B for fiscal 2025.
What is West Pharmaceutical Services' annual revenue history?
West Pharmaceutical Services' annual revenue by fiscal year: 2020: $2.15B; 2021: $2.83B; 2022: $2.89B; 2023: $2.95B; 2024: $2.89B; 2025: $3.07B.
What was West Pharmaceutical Services' net income in fiscal 2025?
West Pharmaceutical Services reported net income of $493.7M for fiscal 2025.
What was West Pharmaceutical Services' earnings per share (EPS) in fiscal 2025?
West Pharmaceutical Services' diluted EPS was $6.79 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did West Pharmaceutical Services generate in fiscal 2025?
West Pharmaceutical Services generated $468.9M of free cash flow in fiscal 2025.
What was West Pharmaceutical Services' revenue last quarter?
In its most recent reported quarter (2026 Q2), West Pharmaceutical Services reported revenue of $872.3M.
How much debt does West Pharmaceutical Services have?
West Pharmaceutical Services reported $202.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of West Pharmaceutical Services are outstanding?
West Pharmaceutical Services reported a weighted average of 70.8 million basic shares outstanding in 2026 Q2.
What is West Pharmaceutical Services' market cap?
Based on its latest closing price, West Pharmaceutical Services (WST) has a market capitalization of about $26.51B.
When does West Pharmaceutical Services' fiscal year end?
West Pharmaceutical Services' fiscal year end, as registered with the SEC, is December 31.
Where is West Pharmaceutical Services headquartered?
West Pharmaceutical Services lists its business address in Exton, Pennsylvania in its SEC filings.
West Pharmaceutical Services Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →